As previously described in an anephric aHUS patient, with a CFH disease-associated haplotype as well as CFI and CFB variants, the patient had evidence of complement activation, developed carotid artery stenosis, and was successfully treated with eculizumab (67). This evidence concerns the gene CFI and coronary atherosclerosis measurement.